NOI_1152034.pdf

Synopsis – Notice of Intent to Sole Source

This synopsis is hereby issued in accordance with FAR Part 5.203 in response to the mandatory requirement for a 15 day notification. The purpose of this synopsis is to announce the Food and Drug Administration’s intent to negotiate a Firm Fixed Price sole source contract with PACIFIC BIOSCIENCES OF CALIFORNIA, INC., located at 1380 Willow Rd., Menlo Park, CA 94025-1439 for a service agreement for a Pacbio RSII sequencing machine currently in possession of the FDA’s CFSAN. The Government intends to negotiate solely with PACIFIC BIOSCIENCES OF CALIFORNIA, INC. as they are the only manufacturer of the sequencing machine, and distributor of parts required for a service agreement that does not void the equipment warranty. The Food and Drug Administration intends to purchase the following quantity:

One (1) Base Year: [100-236-400] Standard PacBio Service Contract.

Four (4) Option Years: [100-236-400] Standard PacBio Service Contract.

THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE PROPOSALS, however, interested firms may submit a capability statement in response to the above requirement with pricing information by August 19th, 2015@ 4:30 PM Local Time to Christopher McGucken, Contract Specialist, Phone:

(240) 402-7599, Email: Christopher.McGucken@fda.hhs.gov. A determination not to open competition based responses to this notice is solely within the discretion of the Government.